Symptom Inventory for Gastrointestinal Stromal Tumors

Status unconfirmed

Conditions studied: Gastrointestinal Stromal Tumors

In brief

The goal of this research study is to better understand the symptoms experienced by patients with GIST. There are 3 parts to this study. In Part 1, participants will complete 1 set of interviews and questionnaires about GIST symptoms. In Part 2, the importance of some symptoms to patients with GIST will be rated by doctors, nurses, patients, and family caregivers. In Part 3, participants will complete questionnaires about GIST symptoms over 1 year. You are being asked to take part in Part 3 of the study.

Key facts

Study ID

NCT01178307

Run by

M.D. Anderson Cancer Center

People needed

187

Starts

2010-07-29

Expected to finish

2020-07-31

Last updated by the study team

2020-01-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years of age or older (Patient and family caregiver only)
• Ability to speak and read English (All participants)
• Residing where IVR service is available (Part 3, Patient only)
• Diagnosis of GIST confirmed by pathological analysis (Patient only)
• Starting new treatment (either surgical or medical) and planning to be followed at M.D. Anderson Cancer Center (Part 3, Patient only)
• Written consent to participate (All participants)
• At least 3 months from start of initial treatment (surgical or medical) for GIST (Part 2, Patient only)
• Family caregiver also willing to receive packet for expert panel participation (Part 2, Patient only)
• Physician or nurse with at least 5 years experience caring for patients with GIST (Professional expert only)
• At least one publication in the last 5 years dealing with GIST (Physician professional expert only)
• Identification as a family caregiver by a patient with GIST (Family caregiver only)
• Patient also willing to receive packet for expert panel participation (Family caregiver only)

You may not qualify if…

• Medical condition or impaired performance status that would preclude participation in the study (Patient only)
• Diagnosis of active psychosis or severe cognitive impairment as determined by primary physician (Patient only)
• Active treatment (systemic drug therapy or radiation therapy) for a second malignancy (Patient only)

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.